These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 23382875)

  • 1. Molecular determinants of epidermal growth factor binding: a molecular dynamics study.
    Sanders JM; Wampole ME; Thakur ML; Wickstrom E
    PLoS One; 2013; 8(1):e54136. PubMed ID: 23382875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The extracellular domain of the epidermal growth factor receptor. Studies on the affinity and stoichiometry of binding, receptor dimerization and a binding-domain mutant.
    Brown PM; Debanne MT; Grothe S; Bergsma D; Caron M; Kay C; O'Connor-McCourt MD
    Eur J Biochem; 1994 Oct; 225(1):223-33. PubMed ID: 7925442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative experimental/theoretical studies on the EGFR dimerization under the effect of EGF/EGF analogues binding: Highlighting the importance of EGF/EGFR interactions at site III interface.
    Mehrabi M; Mahdiuni H; Rasouli H; Mansouri K; Shahlaei M; Khodarahmi R
    Int J Biol Macromol; 2018 Aug; 115():401-417. PubMed ID: 29665393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of single-mutant epidermal growth factor (EGF) ligands alters the stability of the EGF receptor dimer and promotes growth signaling.
    Pascarelli S; Merzhakupova D; Uechi GI; Laurino P
    J Biol Chem; 2021 Jul; 297(1):100872. PubMed ID: 34126069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replacement of N-terminal portions of TGF-alpha with corresponding heregulin sequences affects ligand-induced receptor signaling and intoxication of tumor cells by chimeric growth-factor toxins.
    Schmidt M; Wels W
    Int J Cancer; 2002 Jan; 97(3):349-56. PubMed ID: 11774287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor contains both positive and negative determinants for interaction with ErbB-2/ErbB-3 heterodimers.
    Stortelers C; van De Poll ML; Lenferink AE; Gadellaa MM; van Zoelen C; van Zoelen EJ
    Biochemistry; 2002 Apr; 41(13):4292-301. PubMed ID: 11914075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of an epidermal growth factor/transforming growth factor alpha tail chimera with the human epidermal growth factor receptor reveals unexpected complexities.
    Puddicombe SM; Wood L; Chamberlin SG; Davies DE
    J Biol Chem; 1996 Nov; 271(48):30392-7. PubMed ID: 8940002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnitude of Ubiquitination Determines the Fate of Epidermal Growth Factor Receptor Upon Ligand Stimulation.
    Akimov V; Fehling-Kaschek M; Barrio-Hernandez I; Puglia M; Bunkenborg J; Nielsen MM; Timmer J; Dengjel J; Blagoev B
    J Mol Biol; 2021 Oct; 433(21):167240. PubMed ID: 34508725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational optimization of a bispecific ligand trap targeting EGF receptor family ligands.
    Jin P; Zhang J; Beryt M; Turin L; Brdlik C; Feng Y; Bai X; Liu J; Jorgensen B; Shepard HM
    Mol Med; 2009; 15(1-2):11-20. PubMed ID: 19048033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CR1/CR2 interactions modulate the functions of the cell surface epidermal growth factor receptor.
    Walker F; Orchard SG; Jorissen RN; Hall NE; Zhang HH; Hoyne PA; Adams TE; Johns TG; Ward C; Garrett TP; Zhu HJ; Nerrie M; Scott AM; Nice EC; Burgess AW
    J Biol Chem; 2004 May; 279(21):22387-98. PubMed ID: 15016810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ErbB/HER family of protein-tyrosine kinases and cancer.
    Roskoski R
    Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A variant epidermal growth factor receptor exhibits altered type alpha transforming growth factor binding and transmembrane signaling.
    Moriai T; Kobrin MS; Hope C; Speck L; Korc M
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):10217-21. PubMed ID: 7937865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-cell structural dynamics of an EGF receptor during ligand-induced dimer-oligomer transition.
    Kozer N; Clayton AHA
    Eur Biophys J; 2020 Jan; 49(1):21-37. PubMed ID: 31740999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains.
    Ogiso H; Ishitani R; Nureki O; Fukai S; Yamanaka M; Kim JH; Saito K; Sakamoto A; Inoue M; Shirouzu M; Yokoyama S
    Cell; 2002 Sep; 110(6):775-87. PubMed ID: 12297050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the molecular basis of EGFR kinase domain/MIG-6 peptide recognition complex using computational analyses.
    Moonrin N; Songtawee N; Rattanabunyong S; Chunsrivirot S; Mokmak W; Tongsima S; Choowongkomon K
    BMC Bioinformatics; 2015 Mar; 16():103. PubMed ID: 25885222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docking and molecular dynamics simulation study of EGFR1 with EGF-like peptides to understand molecular interactions.
    Sudhakar DR; P K; Subbarao N
    Mol Biosyst; 2016 May; 12(6):1987-95. PubMed ID: 27072492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational stability of the epidermal growth factor (EGF) receptor as influenced by glycosylation, dimerization and EGF hormone binding.
    Taylor ES; Pol-Fachin L; Lins RD; Lower SK
    Proteins; 2017 Apr; 85(4):561-570. PubMed ID: 28019699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand regulates epidermal growth factor receptor kinase specificity: activation increases preference for GAB1 and SHC versus autophosphorylation sites.
    Fan YX; Wong L; Deb TB; Johnson GR
    J Biol Chem; 2004 Sep; 279(37):38143-50. PubMed ID: 15231819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane interaction of bound ligands contributes to the negative binding cooperativity of the EGF receptor.
    Arkhipov A; Shan Y; Kim ET; Shaw DE
    PLoS Comput Biol; 2014 Jul; 10(7):e1003742. PubMed ID: 25058506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bipartite tetracysteine display reveals allosteric control of ligand-specific EGFR activation.
    Scheck RA; Lowder MA; Appelbaum JS; Schepartz A
    ACS Chem Biol; 2012 Aug; 7(8):1367-76. PubMed ID: 22667988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.